AzTrials
AzTrials

Mental HealthNCT05738122

Evaluating the Efficacy of a 60-day Emotion Regulation Journal

A study testing 60-Day self-guided Emotion Regulation Journal in people with Mental Health and Emotional Regulation, run by University of Victoria at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Participants randomized to the intervention group will receive a physical copy of the 60-day emotion regulation journal during the baseline meeting. Participants will also be introduced the purpose of the journal and its intended usage (i.e., daily journaling). Read more about this study

Who is it for?
Ages 19 years and olderHealthy volunteers can take part
Conditions the study is for
Mental Health, Emotional Regulation
What is being tested?
60-Day self-guided Emotion Regulation Journal
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteCanada
Study dates
18 Jan 2023to 11 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • (1) being 18+ years old (2) being fluent in English, (3) currently living in the Greater Victoria area, (4) self-reporting no previously diagnosed mental illness or psychiatric conditions, and (5) scoring a mean of <4.6 on the Cognitive Reappraisal, and mean of >3.14 on the Expressive Suppression subscales of the Emotion Regulation Questionnaire (based on previous mean data)

Who cannot join

  • Scoring a mean of ≥4.6 on the Cognitive Reappraisal or a mean of ≤3.14 on the Expressive Suppression subscales of the Emotion Regulation Questionnaire, currently receiving or seeking therapy for a mental illness, a current or previous diagnosis of mental illness, or self-identifying as neurodivergent.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Behavioural Medicine Lab - University of Victoria

    Victoria, British Columbia, V8P 5C2

Other trials in Canada

About this study

Official title: Evaluating the Efficacy of a 60-day Self-guided Emotion Regulation Journal

Participants randomized to the intervention group will receive a physical copy of the 60-day emotion regulation journal during the baseline meeting. Participants will also be introduced the purpose of the journal and its intended usage (i.e., daily journaling). Intervention participants will not be offered guidance or feedback on the journal after these initial instructions, in order to emulate an ad libitum usage. Control group participants will not receive any contact with the researchers outside of the planned questionnaires and to receive their journal at the two-month timepoint.

Being tested
60-Day self-guided Emotion Regulation Journal
Medical subject headings
Psychological Well-Being, Emotional Regulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 60-Day self-guided Emotion Regulation JournalOther

    A 60-day self guided journal with activities designed to be completed daily to improve an individual's emotion regulation abilities and habits

Study groups in NCT05738122
Study groupRoleWhat they receive
Intervention (Journal Group)ExperimentalParticipants in the Intervention group are provided with the 60-day self-guided emotion regulation journals upon enrolment in the study. These participants complete surveys at 2 weeks, 1 month, and 2 months. After the 60-day period, these participants also complete an exit interview and a follow-up survey.
Receives: Other: 60-Day self-guided Emotion Regulation Journal
Control (Waitlist Group)No interventionParticipants in the Waitlist group complete a 2-week, 1-month and 2-month survey. After the 60-day period, they receive access to the 60-day self-guided emotion regulation journal for their own use.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Participant Emotion Regulation

    Change in participants' emotion regulation abilities and habits assessed using the Emotion Regulation Questionnaire.

    Measured: 2 weeks, 1-month, 2-months, 60 day exit interview, 90 days follow up

  2. Participant Emotion Regulation

    Change in participants' emotion regulation abilities and habits assessed using the using the Difficulties in Emotional Regulation.

    Measured: 2 weeks, 1-month, 2-months, 60 day exit interview, 90 days follow up

Secondary outcomes (9)
  1. Adherence

    Participants' adherence to the 60-days of activities in the journal assessed using three items: "Currently, what is the last day of the journal you have completed?"; "Have you skipped or not completed any days prior to the latest day you have completed?"; and "Approximately how many minutes do you spend completing a day, within the journal?"

    Measured: 2 weeks, 1-month, 2-months

  2. Experience using journal

    Usability and user experience of intervention group collected during exit interview

    Measured: 60 days

  3. Demographics

    Age, preferred gender, socio-economic status, ethnicity, educational attainment, and employment status will be collected.

    Measured: Baseline

  4. Mental Health

    Depression and anxiety will be assessed using the Hospital Anxiety and Depression Scale. There is a minimum score of 0 and a maximum score of 21 for each anxiety and depression. Individuals with a score of greater than 8 are considered to have considerable symptoms of anxiety and/or depression.

    Measured: 2 weeks, 1-month, 2-months, and 3-month follow up for intervention group

  5. Subjective Well-Being

    Subjective well-being will be assessed using the Warwick-Edinburgh Mental Wellbeing Scale. There is a minimum score of 14 and a maximum score of 70. Scores above 51 are above mean population mental well-being while a score below 51 is below mean population mental well-being.

    Measured: 2 weeks, 1-month, 2-months, and 3-month follow up for intervention group

  6. Self-Compassion

    Self-Compassion will be assessed using the full version of the Self-Compassion Scale. Minimum score is 1 and Maximum score is 5. Scores from 1-2.5 indicate low self-compassion, 2.5-3.5 indicates moderate, and 3.5-5 indicates high self-compassion.

    Measured: 2 weeks, 1-month, 2-months, and 3-month follow up for intervention group

  7. Physical Activity and Sedentary Behaviour

    Past week hours of sitting, walking, mild, moderate, and vigorous physical activity will be assessed using a modified version of the International Physical Activity Questionnaire. A HIGH score consists of vigorous intensity activity on at least 3 days OR 7 or more days of any combination of walking, moderate intensity or vigorous intensity activities. A MODERATE score consists of 3 or more days of vigorous intensity activity and/or walking of at least 30 minutes per day OR 5 or more days of moderate intensity activity and/or walking of at least 30 minutes per day OR 5 or more days of any combination of walking, moderate intensity or vigorous intensity activities. A LOW score is not achieving the high or moderate physical activity levels.

    Measured: 2 weeks, 1-month, 2-month, and 3-month follow up for intervention group

  8. Screen Time

    Past week average weekday and weekend occupational and recreational (i.e., leisure) screen time hours will be assessed using four bespoke items (e.g., In the last seven days, on an average weekday, how many hours did you spend using screens for recreational purposes (e.g., watching TV, playing video games)?)

    Measured: 2 weeks, 1-month, 2-month, and 3-month follow up for intervention group

  9. Sleep

    Past week average hours of sleep will be assessed using an adapted item from the Pittsburgh Sleep Quality Assessment: 20 "During the past week, how many hours of actual sleep did you get at night?". The minimum score is 0 representing 7 or more hours of sleep and the maximum score is 3 representing less than 5 hours of sleep. The higher the score, the worse the sleep duration.

    Measured: 2 weeks, 1-month, 2-month, and 3-month follow up for intervention group

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2023
  2. Study start18 Jan 2023
  3. Primary completion11 Nov 2023
  4. Study completion11 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05738122
Sponsor's protocol ID
22-0469
Status last verified
Apr 2025
First submitted
3 Feb 2023
Last updated
8 Apr 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing 60-Day self-guided Emotion Regulation Journal in people with Mental Health and Emotional Regulation, run by University of Victoria at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Participant Emotion Regulation (time frame: 2 weeks, 1-month, 2-months, 60 day exit interview, 90 days follow up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in